Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension – Page 146

Is Longevity Science Worth It?

How long would you like to live, and could science and technology make it possible?

Longevity science aims to extend our healthy years through advancements in CRISPR, cellular reprogramming, and drug development. While private companies and philanthropists invest heavily in these innovations, should the government be responsible for funding these efforts? Those who say yes to government funding say that longevity research could revolutionize public health, keep aging populations productive in the workforce, and reduce the economic burden of age-related illnesses. Those opposed to public funding of longevity science say that true life extension beyond a decade might be unachievable, and it will take years before results are measurable.


They argue that when and if these advances become available, they may only be for a smaller, affluent population. They also argue that long-known behavior choices like good nutrition and sleep should be adopted by all now, instead of chasing uncertain longevity advancements.

With this context, we debate the question: Could Longevity Science Extend Your Health Span By Decades? Should the Government Fund It?

Immunosenescence, Inflammaging, And Immune Resilience: Matt Yousefzadeh, PhD

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links/Affiliates:
Blood testing (where I get the majority of my labs): https://www.ultalabtests.com/partners/michaellustgarten.

At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

Clearly Filtered Water Filter: https://get.aspr.app/SHoPY

Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/

Continue reading “Immunosenescence, Inflammaging, And Immune Resilience: Matt Yousefzadeh, PhD” | >

Dr. Debra Whitman, Ph.D. — Chief Public Policy Officer, AARP — Author, The Second Fifty

Exploring the most important questions we face as we age.

Dr. Debra Whitman, Ph.D. is Executive Vice President and Chief Public Policy Officer, at AARP (https://www.aarp.org/) where she leads policy development, analysis and research, as well as global thought leadership supporting and advancing the interests of individuals age 50-plus and their families. She oversees AARP’s Public Policy Institute, AARP Research, Office of Policy Development and Integration, Thought Leadership, and AARP International.

Dr. Whitman is an authority on aging issues with extensive experience in national policy making, domestic and international research, and the political process. An economist, she is a strategic thinker whose career has been dedicated to solving problems affecting economic and health security, and other issues related to population aging.

As staff director for the U.S. Senate Special Committee on Aging, Dr. Whitman worked across the aisle to increase retirement security, lower the cost of health care, protect vulnerable seniors, safeguard consumers, make the pharmaceutical industry more transparent, and improve our nation’s long term care system.

Before that, Dr. Whitman worked for the Congressional Research Service as a specialist in the economics of aging. She provided members of Congress and their staff with research and advice, and authored analytical reports on the economic impacts of current policies affecting older Americans, as well as the distributional and intergenerational effects of legislative proposals.

Continue reading “Dr. Debra Whitman, Ph.D. — Chief Public Policy Officer, AARP — Author, The Second Fifty” | >

Anti-Ageing Influencer Bryan Johnson Ditches ‘Longevity’ Medicine Over Health Concerns

🔗: https://bit.ly/3ZOWVH7

The Moon still holds mysteries that leave scientists in awe. A massive, heat-radiating object beneath its surface has sparked new questions about its origins.

This discovery offers a glimpse into the Moon’s hidden history, challenging what we thought we knew about our celestial neighbor.

Bryan Johnson said taking rapamycin may have done more harm than good to his health.

Discovery of new skeletal tissue advances regenerative medicine potential

An international research team led by the University of California, Irvine has discovered a new type of skeletal tissue that offers great potential for advancing regenerative medicine and tissue engineering.

Most cartilage relies on an external extracellular matrix for strength, but “lipocartilage,” which is found in the ears, nose and throat of mammals, is uniquely packed with fat-filled cells called “lipochondrocytes” that provide super-stable internal support, enabling the tissue to remain soft and springy—similar to bubbled packaging material.

The study, published in the journal Science, describes how lipocartilage cells create and maintain their own lipid reservoirs, remaining constant in size. Unlike ordinary adipocyte fat cells, lipochondrocytes never shrink or expand in response to food availability.

World’s first cryopreservation facility could unlock immortality, delay death

Think of a future where terminal illnesses can be temporarily halted, allowing time for the development of potential cures.

TimeShift, the world’s first cryopreservation facility, seeks to make the impossible – extending human lifespan – a reality.

The conceptualized facility would provide a means of freezing or preserving patients’ bodies with terminal illnesses. This way, it could mitigate the progression of neurodegenerative diseases and aggressive cancers. And possibly enable experts to develop a cure.

82 Year Old Longevity Biohacker’s Experience With Follistatin Gene Therapy

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links/Affiliates:
Blood testing (where I get the majority of my labs): https://www.ultalabtests.com/partners/michaellustgarten.

At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

Clearly Filtered Water Filter: https://get.aspr.app/SHoPY

Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/

Continue reading “82 Year Old Longevity Biohacker’s Experience With Follistatin Gene Therapy” | >

‘Blaze Star’ Set To Dazzle Sky-Watchers For First Time Since 1946

T Coronae Borealis (T CrB) is a binary star system comprising two stars at very different stages of their life cycles: a red giant and a white dwarf. The red giant, an aging star, is expanding as it nears the end of its life, shedding layers of material into space. Meanwhile, the white dwarf, a stellar remnant that has burned through its fuel, is steadily cooling. This system draws the red giant’s expelled material toward the white dwarf’s surface. When enough accumulates, it triggers a thermonuclear explosion, creating a dramatic outburst of energy and light.

Astronomers know about the “Blaze Star” because it’s had sudden outbursts before. They even know there is usually a decade-long uptick in brightness before the explosion, preceded by a noticeable dip in brightness. That 10-year uptick was reported in a paper in 2023, while the American Association of Variable Star Observers announced T CrB’s pre-eruption dip in April 2024.

Something to bear in mind is that this is a rare astronomical event, but only committed stargazers are likely to get much out of it.

/* */